Cargando…

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis

AIMS: The management of ostial lesions is one of the challenges of percutaneous coronary intervention (PCI) in recent medicine. Although stent implantation has increased the accuracy of the results and improved long-term outcomes, in-stent restenosis (ISR) occurs more frequency following the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wei-Chieh, Fang, Hsiu-Yu, Chung, Wen-Jung, Hsueh, Shu-Kai, Chen, Chien-Jen, Yang, Cheng-Hsu, Yip, Hon-Kan, Hang, Chi-Ling, Wu, Chiung-Jen, Fang, Chih-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441315/ https://www.ncbi.nlm.nih.gov/pubmed/28616511 http://dx.doi.org/10.1016/j.ijcha.2015.11.003

Ejemplares similares

Associations Between Target Lesion Restenosis and Drug-Eluting Balloon Use: An Observational Study
por: Lee, Wei-Chieh, et al.
Publicado: (2016)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction
por: Lee, Wei-Chieh, et al.
Publicado: (2016)

Transradial percutaneous coronary intervention for chronic total occlusion of coronary artery disease using sheathless standard guiding catheters
por: Chen, Huang-Chung, et al.
Publicado: (2014)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis
por: Chong, Shaur-Zheng, et al.
Publicado: (2018)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

One-Year Outcomes After Everolimus-Eluting Stents Implantation in Ostial Lesions of Left Anterior Descending Coronary Arteries
por: Golmohamadi, Zahra, et al.
Publicado: (2013)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Management of Coronary Ostial Stenosis with Drug Coated Balloons: Technical and Clinical Aspects
por: Yalta, Kenan, et al.
Publicado: (2022)

Coronary allograft vasculopathy managed by Flash ostial balloon in a pediatric patient
por: Desai, Viral K., et al.
Publicado: (2021)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

How to treat the combination of coronary artery fistula and occluded coronary artery: A case report
por: Lee, Wei-Chieh, et al.
Publicado: (2018)

Local drug-delivery balloon for proliferative occlusive in-stent restenosis after drug-eluting stent
por: Rigatelli, Gianluca, et al.
Publicado: (2011)

Safety and Feasibility of Coronary Stenting in Unprotected Left Main Coronary Artery Disease in the Real World Clinical Practice—A Single Center Experience
por: Lee, Wei-Chieh, et al.
Publicado: (2014)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Application of a snare technique in retrograde chronic total occlusion percutaneous coronary intervention – a step by step practical approach and an observational study
por: Fang, Hsiu-Yu, et al.
Publicado: (2016)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies
por: Gao, Lei, et al.
Publicado: (2019)

Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty – case report and review of the literature
por: Vassilev, Dobrin, et al.
Publicado: (2015)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
por: Pleva, Leos, et al.
Publicado: (2017)

Intrastent haematoma after treatment with a drug-eluting balloon for in-stent restenosis: a case report
por: Hong, Xu-Lin, et al.
Publicado: (2021)

The Clinical Outcomes Based on the Achievement of Low-Density Lipoprotein Cholesterol Targets after ST Elevation Myocardial Infarction
por: Lee, Wei-Chieh, et al.
Publicado: (2019)

Feasibility and Safety of Chronic Total Occlusion Percutaneous Coronary Intervention via Distal Transradial Access
por: Lin, Cheng-Jui, et al.
Publicado: (2021)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

Retrospective study of treatment with a drug-coated balloon alone is beneficial for ostial coronary lesions
por: Zhang, Wenduo, et al.
Publicado: (2022)

Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report
por: Giordano, Arturo, et al.
Publicado: (2016)

Aortic and Coronary Ostial Stenoses
Publicado: (2001)

Challenging Intervention to Restenosis of Right Coronary Ostial Stent Excessively Overhanging to the Aorta: A Case Report and Brief Review of Literature
por: Esenboğa, Kerim, et al.
Publicado: (2022)

Value of S100A12 in predicting in-stent restenosis in patients with coronary drug-eluting stent implantation
por: Liang, Hengyi, et al.
Publicado: (2020)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
por: Nijhoff, Freek, et al.
Publicado: (2015)

Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease
por: Lee, Wei-Chieh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kofp8st8nq8ttgav6jft2m46u6